HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paulraj Kanmani Selected Research

Paulraj Kanmani Research Topics

Disease

3Inflammation (Inflammations)
01/2018 - 03/2015
2Lung Injury
06/2021 - 08/2015
2Pneumococcal Infections
06/2021 - 05/2020
2Pneumococcal Pneumonia
01/2017 - 01/2017
2Respiratory Syncytial Virus Infections
01/2017 - 01/2017
2Infections
01/2016 - 08/2015
1Fibrosis (Cirrhosis)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1Pneumonia (Pneumonitis)
01/2017
1Superinfection
01/2017
1Virus Diseases (Viral Diseases)
01/2017
1Bacteremia
01/2017
1Communicable Diseases (Infectious Diseases)
01/2017
1Body Weight (Weight, Body)
08/2013
1Edema (Dropsy)
08/2013

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
06/2021 - 08/2015
3Toll-Like Receptors (Toll-Like Receptor)IBA
05/2020 - 01/2017
2Antiviral Agents (Antivirals)IBA
01/2017 - 01/2017
2MD1IBA
08/2016 - 03/2015
1Proteins (Proteins, Gene)FDA Link
01/2022
1Mitogen-Activated Protein KinasesIBA
01/2018
1EndotoxinsIBA
01/2018
1Peptidoglycan (Murein)IBA
01/2017
1Toll-Like Receptor 3IBA
01/2017
1InterferonsIBA
01/2016
12-5A-dependent ribonuclease (RNase L)IBA
01/2016
1Interleukin-10 (Interleukin 10)IBA
08/2015
1CarrageenanIBA
08/2013
1Freund's AdjuvantIBA
08/2013
1spiropyran (HO-Sp)IBA
08/2013

Therapy/Procedure

1Intranasal Administration
08/2015
1Aftercare (After-Treatment)
08/2013